Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children

Choi, Soo-Han; Jo, Yoon Hee; Jo, Kyo Jin; Park, Su Eun

doi:10.3346/jkms.2021.36.e227

Cited by 67 publications

(90 citation statements)

References 16 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In October 2021, 2 weeks prior to the anticipated FDA approval for COVID-19 vaccination of children between the ages of 5 and 11 years, only 41% of a racially and ethnically diverse national sample of female guardians planned to have their young children vaccinated, 25% were unsure, and 34% were unwilling. This percentage is consistent with most prior reports of COVID-19 vaccination rates for children 12-17 years of age and anticipated rates for the emergency use approval for children 5-11 years of age [6][7][8][9][10][11][12][13][14][15]. However, rates significantly differed across racial/ethnic groups with 62% of non-Hispanic Asian parents compared to 31% non-Hispanic Black, 45% Hispanic, and 25% non-Hispanic White planning to vaccinate their child following FDA approval.…”

Section: Discussionsupporting

confidence: 86%

“…Since the vaccine was approved for children 12-17 years of age, US vaccination rates for this age group have been reported at 42% for the first dose and 32% for series completion [6]. Emerging data on parental intentions to have their 5-11-year-old children vaccinated for COVID-19 following FDA approval have reported similar rates ranging from 44% to 63% in the U.S. [7][8][9][10] and these are consistent with data from across the globe [11][12][13][14][15]. These percentages are troubling since population modeling indicates that vaccinating adolescents and children could reduce overall COVID-related mortality and case load [16].…”

Section: Introductionsupporting

confidence: 70%

See 1 more Smart Citation

COVID-19 Pediatric Vaccine Hesitancy among Racially Diverse Parents in the United States

2021

View full text Add to dashboard Cite

On 29 October 2021, the U.S. FDA authorized the Pfizer-BioNTech COVID-19 (SARS-CoV-2) vaccine for emergency use in children ages 5–11 years. Racial/ethnic minorities have born the greatest burden of pediatric COVID-19 infection and hospitalization. Research indicates high prevalence of parental vaccine hesitancy among the general population, underscoring the urgency of understanding how race/ethnicity may influence parents’ decision to vaccinate their children. Two weeks prior to FDA approval, 400 Hispanic and non-Hispanic Asian, Black, and White parents of children 5–10 years participated in an online survey assessing determinants of COVID-19 pediatric vaccine hesitancy. Compared to 31% Black, 45% Hispanic, and 25% White parents, 62% of Asian parents planned to vaccinate their child. Bivariate and multivariate ordinal logistic regression demonstrated race/ethnicity, parental vaccine status, education, financial security, perceived childhood COVID-19 susceptibility and severity, vaccine safety and efficacy concerns, community support, and FDA and physician recommendations accounted for 70.3% of variance for vaccine hesitancy. Findings underscore the importance of multipronged population targeted approaches to increase pediatric COVID-19 vaccine uptake including integrating health science literacy with safety and efficacy messaging, communication efforts tailored to parents who express unwillingness to vaccinate, and interventions developed in partnership with and delivered through existing trusted community coalitions.

show abstract

Section: Discussionsupporting

confidence: 86%

Section: Introductionsupporting

confidence: 70%

COVID-19 Pediatric Vaccine Hesitancy among Racially Diverse Parents in the United States

2021

View full text Add to dashboard Cite

show abstract

“…We would expect that given guardians who completed surveys had children with more severe illness, families would be more willing to accept a vaccine, however, our findings are congruent with the CDC’s recent report of 48% of 16–17 year-olds and 39% of 12–15 year-olds who are fully vaccinated in the US as of 8 September 2021 [ 19 , 20 ]. In a recent study conducted in South Korea, guardians had a higher reported intent to vaccinate their child at 64.2%, mirroring their confidence in the effectiveness of COVID-19 vaccines of 64.8% [ 21 ]. In our study, adding a positive efficacy fact to the question in the second survey, appeared to influence guardians’ intent to vaccinate their child.…”

Section: Discussionmentioning

confidence: 99%

Intent to Vaccinate SARS-CoV-2 Infected Children in US Households: A Survey

et al. 2021

View full text Add to dashboard Cite

A paucity of data exists evaluating a guardian’s intent to vaccinate their child against COVID-19 in the United States. We administered 102 first (April–November 2020) and 45 second (December–January 2020–2021) surveys to guardians of children (<18 years) who had a laboratory-confirmed diagnosis of COVID-19 and assessed their intent to give a COVID-19 vaccine to their child, when one becomes available. The first and second surveys of the same cohort of guardians were conducted before and following the press releases detailing the adult Pfizer-BioNTech and Moderna Phase 3 results. Both surveys included an intent-to-vaccinate question using the subjective language of “if a safe and effective vaccine” became available, and a second question was added to second surveys using the objective language of “would prevent 19 of 20 people from getting disease”. When using subjective language, 24 of 45 (53%) guardians endorsed vaccine administration for their children in the first survey, which decreased to 21 (46%) in the second survey. When adding objective language, acceptance of vaccination increased to 31 (69%, p = 0.03). Common reasons for declining vaccination were concerns about adverse effects and/or vaccine safety. Providing additional facts on vaccine efficacy increased vaccine acceptance. Evidence-based strategies are needed to increase pediatric COVID-19 vaccine uptake.

show abstract

“…June 2021 among parents/guardians in South Korea and involving 226 participants reported an overall COVID-19 vaccine acceptance rate of 76.5% 79. An earlier global study by de Figueiredo and Larson, that was conducted during October-December 2020 involved 1103 participants from the country has shown an acceptance rate of 86.6% for COVID-19 vaccination.80 https://doi.org/10.2147/JMDH.S347669 DovePress Journal of Multidisciplinary Healthcare 2022:15 28 Sallam et al Dovepress Powered by TCPDF (www.tcpdf.org) Powered by TCPDF (www.tcpdf.org)…”

mentioning

confidence: 99%

A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

Sallam¹,

Alsanafi²,

Sallam³

2022

JMDH

178

151

View full text Add to dashboard Cite

The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to successful control of COVID-19 epidemic. The huge number of publications addressing COVID-19 vaccine hesitancy necessitates periodic review to provide a concise summary of COVID-19 vaccine acceptance rates worldwide. In the current narrative review, data on COVID-19 vaccine acceptance rates were retrieved from surveys in 114 countries/ territories. In East and Southern Africa (n = 9), the highest COVID-19 vaccine acceptance rate was reported in Ethiopia (92%), while the lowest rate was reported in Zimbabwe (50%). In West/ Central Africa (n = 13), the highest rate was reported in Niger (93%), while the lowest rate was reported in Cameroon (15%). In Asia and the Pacific (n = 16), the highest rates were reported in Nepal and Vietnam (97%), while the lowest rate was reported in Hong Kong (42%). In Eastern Europe/Central Asia (n = 7), the highest rates were reported in Montenegro (69%) and Kazakhstan (64%), while the lowest rate was reported in Russia (30%). In Latin America and the Caribbean (n = 20), the highest rate was reported in Mexico (88%), while the lowest rate was reported in Haiti (43%). In the Middle East/North Africa (MENA, n = 22), the highest rate was reported in Tunisia (92%), while the lowest rate was reported in Iraq (13%). In Western/Central Europe and North America (n = 27), the highest rates were reported in Canada (91%) and Norway (89%), while the lowest rates were reported in Cyprus and Portugal (35%). COVID-19 vaccine acceptance rates ≥60% were seen in 72/114 countries/territories, compared to 42 countries/territories with rates between 13% and 59%. The phenomenon of COVID-19 vaccine hesitancy appeared more pronounced in the MENA, Europe and Central Asia, and Western/ Central Africa. More studies are recommended in Africa, Eastern Europe and Central Asia to address intentions of the general public to get COVID-19 vaccination.

show abstract

Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children

Cited by 67 publications

References 16 publications

COVID-19 Pediatric Vaccine Hesitancy among Racially Diverse Parents in the United States

COVID-19 Pediatric Vaccine Hesitancy among Racially Diverse Parents in the United States

Intent to Vaccinate SARS-CoV-2 Infected Children in US Households: A Survey

A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

Contact Info

Product

Resources

About